Monday

Clinical Trials

The Clinical Trials session focused on promising advances in radiation therapy that helped extend progression-free survival and reduced the need for hormone therapy in patients with recurring prostate cancer, identified the first biomarker to guide hormone therapy and explored the use of low-dose radiation therapy to improve quality of life.

Presidential Symposium envisions a dynamic and collaborative future

ASTRO President Sameer Keole, MD, FASTRO, introduced this year’s symposium topic, centered around the 2025 Annual Meeting’s theme, “Rediscovering Radiation Medicine and Exploring New Indications.”

Impact of MMR Status and Clinicopathologic Risk Factors

This study underscores how molecular testing, including MMR status, will impact practice in adjuvant therapy for endometrial cancer.
By Morgan S. Levy, MD, MPH, University of Kentucky

​​​​​​​Redefining Advanced EGFR-Mutant NSCLC Care

A multicenter phase II trial led by Sagus Sampath, MD, and his team hailing from City of Hope and UT Southwestern
By Eulanca Y. Liu, MD, PhD, UCLA Health